Reversibilidad espirométrica en la enfermedad pulmonar obstructiva crónica: efecto diferencial del salbutamol sobre el volumen espiratorio forzado del primer segundo y el volumen pulmonar

Manríquez H., Jorge; Díaz P., Orlando; Borzone T., Gisella; Lisboa B., Carmen.
Rev. méd. Chile ; 132(7): 787-793, jul. 2004. tab, graf
Artículo en Español | LILACS | ID: lil-366577

Documentos relacionados

  1. A compendium and review of pediatric pulmonary function testing assessment opportunities for asthma.
  2. Product Hopping in the Drug Industry - Lessons from Albuterol.
  3. Pharmacogenetics of Bronchodilator Response: Future Directions.
  4. The effect of a holding chamber on albuterol metered-dose inhaler product differences.
  5. Case report: Paradoxical responses to short acting beta-agonists in a pediatric patient.
  6. Bronchodilator reversibility testing in morbidly obese non-smokers: a comparative study- few concerns.
  7. High frequency percussive ventilation as a rescue mode for refractory status asthmaticus - a case study.
  8. Impact of different nebulisers' connections on aerosol therapy.
  9. Association of various weight-based doses of continuous albuterol on hospital length of stay.
  10. Mesh nebulizer is as effective as jet nebulizer in clinical practice of acute asthma in children